T Stürmer1, H Brenner, W Koenig, K-P Günther. 1. Department of Epidemiology, German Centre for Research on Aging, Heidelberg, Germany. til.sturmer@post.harvard.edu
Abstract
BACKGROUND: Although osteoarthritis (OA) is thought to derive from defective chondrocyte metabolism and thus inherently lack the large scale systemic response of rheumatoid arthritis, there is increasing interest in the acute phase proteins in OA. OBJECTIVE: To assess the association between high sensitivity C reactive protein (hsCRP) and severity and extent of OA in patients with advanced hip and knee OA. METHODS: Preoperative hsCRP was measured in frozen serum samples from 770 consecutive patients with hip or knee joint replacement due to advanced OA recruited between 1995 and 1996. Pain was measured by a visual analogue scale and the Western Ontario and McMaster Universities OA index (WOMAC). The extent of OA in different joints was assessed clinically and radiographically. RESULTS: The (geometric) mean hsCRP was 2.5 mg/l among all patients. Severity of pain was associated with mean hsCRP (adjusted elevation highest v lowest quintile = 35%, p = 0.01) after controlling for known or suspected predictors of hsCRP, including age, smoking, and body mass index. Neither the bilateral nor the generalised extent of OA, nor any of the dimensions of the WOMAC were associated with mean hsCRP levels. CONCLUSIONS: Severity of pain, but not extent of OA, was associated with hsCRP levels in this group of patients with advanced OA. Longitudinal studies with repeated assessments of hsCRP and pain are needed to assess the possible value of hsCRP for monitoring or predicting the clinical course of OA.
BACKGROUND: Although osteoarthritis (OA) is thought to derive from defective chondrocyte metabolism and thus inherently lack the large scale systemic response of rheumatoid arthritis, there is increasing interest in the acute phase proteins in OA. OBJECTIVE: To assess the association between high sensitivity C reactive protein (hsCRP) and severity and extent of OA in patients with advanced hip and knee OA. METHODS: Preoperative hsCRP was measured in frozen serum samples from 770 consecutive patients with hip or knee joint replacement due to advanced OA recruited between 1995 and 1996. Pain was measured by a visual analogue scale and the Western Ontario and McMaster Universities OA index (WOMAC). The extent of OA in different joints was assessed clinically and radiographically. RESULTS: The (geometric) mean hsCRP was 2.5 mg/l among all patients. Severity of pain was associated with mean hsCRP (adjusted elevation highest v lowest quintile = 35%, p = 0.01) after controlling for known or suspected predictors of hsCRP, including age, smoking, and body mass index. Neither the bilateral nor the generalised extent of OA, nor any of the dimensions of the WOMAC were associated with mean hsCRP levels. CONCLUSIONS: Severity of pain, but not extent of OA, was associated with hsCRP levels in this group of patients with advanced OA. Longitudinal studies with repeated assessments of hsCRP and pain are needed to assess the possible value of hsCRP for monitoring or predicting the clinical course of OA.
Authors: Jessica W Smith; Thomas B Martins; Evelyn Gopez; Troy Johnson; Harry R Hill; Thomas D Rosenberg Journal: Ther Adv Musculoskelet Dis Date: 2012-10 Impact factor: 5.346
Authors: Jae-Sung Kim; Kasra Ahmadinia; Xin Li; John L Hamilton; Steven Andrews; Chris A Haralampus; Guozhi Xiao; Hong-Moon Sohn; Jae-Won You; Yo-Seob Seo; Gary S Stein; Andre J Van Wijnen; Su-Gwan Kim; Hee-Jeong Im Journal: J Cell Physiol Date: 2015-11 Impact factor: 6.384
Authors: A H Shadyab; R Terkeltaub; C Kooperberg; A Reiner; C B Eaton; R D Jackson; J L Krok-Schoen; R M Salem; A Z LaCroix Journal: Osteoarthritis Cartilage Date: 2018-05-22 Impact factor: 6.576
Authors: Gregory Livshits; Guangju Zhai; Deborah J Hart; Bernet S Kato; Huizhong Wang; Frances M K Williams; Tim D Spector Journal: Arthritis Rheum Date: 2009-07